Records containing: Relapsing Polychondritis

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-03-20
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
CLINICAL_TRIALS study record update · 2026-02-04
Pragmatic, Open-Label, Two-Stage, Pilot Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis
CLINICAL_TRIALS study record update · 2026-01-23
Longitudinal Study for Relapsing Polychondritis
CLINICAL_TRIALS study record update · 2025-06-17
Biologics in Refractory Vasculitis (BIOVAS): A Pragmatic, Randomised, Double-blind, Placebo-controlled, Modified-crossover Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis in Adults and Children
CLINICAL_TRIALS study record update · 2025-03-12
Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2024-02-26
A Pilot Study of Low Dose IL-2 in the Treatment of Relapsing Polychondritis
CLINICAL_TRIALS study record update · 2023-12-13
ClinicalTrials.gov study NCT03840928
CLINICAL_TRIALS study record update · 2023-11-02
Pediatric Relapsing Polychondritis : Diagnosis and Management in a French Retrospective Study
CLINICAL_TRIALS study record update · 2021-03-03
Efficacy of Tocilizumab in a Patient With Relapsing Polychondritis
CLINICAL_TRIALS study record update · 2014-05-13
Efficacy of Tocilizumab in a Patient With Relapsing Polychondritis
CLINICAL_TRIALS study record update · 2012-08-07
An Open-Label, Single-Center, Phase I Study on the Safety of Abatacept in Relapsing Polychondritis